THE ROLE OF HTA AGENCY IN DRUG REIMBURSEMENT DECISION-MAKING PROCESS IN POLAND (HTA IMPACT)

被引：2
|
作者：
Kolasa, K. [1 ]
机构：
[1] AstraZeneca, Sodertalje, Sweden
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74230-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A251 / A251
页数：1
相关论文
共 50 条
  • [31] Advancing HTA in Latin America: The Policy Process of Setting up an HTA Agency in Colombia
    Castro, Hector E.
    GLOBAL POLICY, 2017, 8 : 97 - 102
  • [32] TOWARDS MORE TRANSPARENT HTA PROCESS IN POLAND - NEW POLISH HTA METHODOLOGICAL GUIDELINES
    Lach, K.
    Dziwisz, M.
    Remuzat, C.
    Toumi, M.
    VALUE IN HEALTH, 2016, 19 (07) : A492 - A492
  • [33] COMPARING THE VALUE OF DIFFERENT HTA DECISION MAKING PROCESS: EVALUATING THE EVALUATORS
    Johannesen, K. M.
    Claxton, K.
    Sculpher, M. J.
    Wailoo, A. J.
    VALUE IN HEALTH, 2013, 16 (07) : A489 - A489
  • [34] BENCHMARKING THE IMPACT OF HTA ON NEW MEDICINES DEVELOPMENT AND COVERAGE DECISION MAKING
    Wang, T.
    VALUE IN HEALTH, 2014, 17 (07) : A798 - A798
  • [35] Expected value of information and decision making in HTA
    Eckermann, Simon
    Willan, Andrew R.
    HEALTH ECONOMICS, 2007, 16 (02) : 195 - 209
  • [36] THE USE OF MCDA IN HTA DECISION MAKING IN BULGARIA
    Sidjimova, D. A.
    Stoimenova, A.
    Benisheva, T.
    Borisov, B.
    Trendafilova, P.
    VALUE IN HEALTH, 2017, 20 (09) : A698 - A698
  • [37] HTA decision-making for drugs for rare diseases: comparison of processes across countries
    Tania Stafinski
    Judith Glennie
    Andrea Young
    Devidas Menon
    Orphanet Journal of Rare Diseases, 17
  • [38] BEST PRACTICES FOR ECA STUDY DESIGN TO SUPPORT HTA DECISION-MAKING IN EUROPE
    Dumuolin, O.
    Vidalis, A.
    Proenca, C.
    VALUE IN HEALTH, 2022, 25 (12) : S339 - S340
  • [39] SHOULD THE PATIENT VOICE HAVE AN ACTIVE ROLE IN HTA DECISION-MAKING? A PAG CONSENSUS ANALYSIS IN GREECE
    Naoum, V
    Naoum, P.
    Karampli, E.
    Athanasakis, K.
    Kyriopoulos, J.
    Pavi, E.
    VALUE IN HEALTH, 2019, 22 : S799 - S799
  • [40] DOES REAL-WORLD EVIDENCE PLAY A ROLE IN DECISION-MAKING BY HTA BODIES FOR MEDICAL TECHNOLOGIES?
    Hartley, L.
    Gildea, L.
    Mordin, M.
    Long, J.
    D'Souza, V
    Kinderas, M.
    Ling, C.
    Warttig, S.
    VALUE IN HEALTH, 2023, 26 (12) : S434 - S435
12345